Seattle, WA, United States of America

Christopher Endres

USPTO Granted Patents = 4 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2014-2022

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Christopher Endres: Innovator in Pharmaceutical Formulations

Introduction

Christopher Endres is a notable inventor based in Seattle, WA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibody formulations for disease treatment. With a total of four patents to his name, Endres has established himself as a key figure in medical innovation.

Latest Patents

Endres's latest patents include a method of treating diseases using an IL-17 receptor antibody formulation. This patent focuses on AM-14 pharmaceutical formulations and therapeutic dosing regimens aimed at effectively treating various diseases. His work in this area highlights the potential of IL-17 receptor antibody formulations in advancing therapeutic options.

Career Highlights

Throughout his career, Christopher Endres has worked with prominent companies in the pharmaceutical industry, including Kirin-Amgen, Inc. and Amgen K.A., Inc. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the field.

Collaborations

Endres has collaborated with esteemed colleagues such as Dingjiang Liu and Holly Zhuohong Huang. These partnerships have further enriched his work and expanded the impact of his innovations.

Conclusion

Christopher Endres is a distinguished inventor whose work in pharmaceutical formulations has the potential to transform disease treatment. His contributions to the field are marked by his innovative patents and collaborations with industry leaders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…